Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
LYEL
Stock Latest News
Ratings
Lyell Immunopharma: Differentiated Dual‑Target CAR‑T Pipeline and Upcoming Clinical Milestones Support Buy Rating and Acquisition Potential
16d ago
LYEL
Premium
The Fly
Lyell Immunopharma price target raised to $39 from $32 at Lucid Capital
26d ago
LYEL
Premium
The Fly
Lyell Immunopharma appoints Smital Shah as CFBO
1M ago
LYEL
Premium
The Fly
Lyell Immunopharma initiated with an Outperform at Citizens
1M ago
LYEL
Premium
Pre-Earnings
LYEL Earnings this Week: How Will it Perform?
1M ago
LYEL
Premium
Company Announcements
Lyell Immunopharma Advances GCC19CART Trial in Metastatic Colorectal Cancer: What Investors Should Know
1M ago
LYEL
Premium
Ratings
Lyell Immunopharma: Differentiated CAR-T Durability and Second-Line LBCL Opportunity Underpin Buy Rating and $45 Target
2M ago
LYEL
Premium
The Fly
Lyell Immunopharma initiates patient dosing in PiNACLE-H2H Phase 3 trial
2M ago
LYEL
Premium
The Fly
Lyell Immunopharma trading resumes
4M ago
LYEL
Premium
The Fly
Lyell Immunopharma trading halted, volatility trading pause
4M ago
LYEL
Premium
The Fly
Lyell Immunopharma upgraded to Buy from Neutral at H.C. Wainwright
4M ago
LYEL
Premium
Company Announcements
Lyell Immunopharma Presents Promising CAR T-Cell Data
4M ago
8K
LYEL
Premium
The Fly
Lyell Immunopharma announces new data from trial of rondecabtagene autoleucel
4M ago
LYEL
Premium
The Fly
Lyell Immunopharma files to sell 1.9M shares of common stock for holders
4M ago
LYEL
Premium
Company Announcements
Lyell Immunopharma Modernizes Bylaws for Shareholder Engagement
4M ago
8K
LYEL
Premium
The Fly
Lyell Immunopharma price target raised to $20 from $10 at H.C. Wainwright
5M ago
LYEL
Premium
Company Announcements
Lyell Immunopharma Reports Q3 2025 Financial Results
5M ago
LYEL
Premium
The Fly
Lyell Immunopharma reports Q3 revenue $15k vs $34k last year
5M ago
LYEL
Premium
The Fly
Lyell Immunopharma acquires exclusive global rights to LYL273
5M ago
LYEL
Premium
Company Announcements
Lyell Immunopharma Secures Global Rights for LYL273
5M ago
8K
LYEL
Premium
Pre-Earnings
LYEL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
LYEL
Premium
Company Announcements
Lyell Immunopharma Appoints New Financial Leadership Team
5M ago
8K
LYEL
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
